Laboratory-Grade Mirtazapine Research Overview
Mirnite 7.5mg is a pharmaceutical preparation containing mirtazapine, a tetracyclic antidepressant compound manufactured by Intas Pharmaceuticals for research applications. Mirtazapine functions as a noradrenergic and specific serotonergic antidepressant (NaSSA), demonstrating complex pharmacological activity through multiple neurotransmitter pathways. This laboratory-grade formulation enables researchers at Stroid UK Shop to investigate the compound’s molecular mechanisms in controlled in-vitro environments. The standardised 7.5mg tablet format provides precise dosing for experimental protocols examining receptor affinity, binding kinetics, and downstream signaling cascades.
Molecular Research Applications
Research scientists utilise Mirnite tablets to examine mirtazapine’s antagonist activity at histamine H1, serotonin 5-HT2A, 5-HT2C, and 5-HT3 receptors, alongside its α2-adrenergic receptor blocking properties. In cellular studies, investigators analyse how the compound’s unique receptor profile influences neurotransmitter release patterns and synaptic transmission models. The pharmaceutical formulation allows researchers studying mirtazapine and related compounds to evaluate bioavailability parameters and metabolic pathways in laboratory settings. Advanced research protocols examine the compound’s interaction with cytochrome P450 enzymes, particularly CYP2D6 and CYP1A2, providing insights into drug metabolism mechanisms relevant to pharmaceutical development studies.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Mirtazapine 7.5mg |
| Manufacturer | Intas Pharmaceuticals |
| Form | Tablet |
| CAS Number | 85650-52-8 |
| Molecular Formula | C17H19N3 |
| Molecular Weight | 265.35 g/mol |
| Storage | Room temperature, dry conditions |
Researchers investigating neuropharmacology alongside other compound classes can explore complementary studies with selective androgen receptor modulators and bioactive peptides to understand multi-target therapeutic approaches in preclinical research models.
Research Compliance Statement
Mirnite 7.5mg tablets are supplied exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines and regulatory requirements when handling pharmaceutical compounds in laboratory settings. All experimental protocols should follow established safety procedures for handling active pharmaceutical ingredients in research applications.
